Rothfuss Cristin sold SRPT
March 4, 2025 · Form 4 insider transaction
Rothfuss Cristin sold 288 shares of Sarepta Therapeutics, Inc. at $101.34 per share, a transaction worth $29.2K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
288
Price
$101.34
Total value
$29.2K
InsiderRothfuss Cristin
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 4, 2025
Filing dateMarch 6, 2025
Shares owned after13,037
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021.